Abstract:VPS35 deficiency or mutation can lead to dysfunction in autophagic–lysosomal pathways, abnormal protein accumulation, mitochondrial dysfunction, and impaired neuronal transmission, thereby promoting the onset of neurodegenerative diseases. Furthermore, VPS deficiency or mutation can result in defects in dendritic terminal differentiation, reduced neuronal proliferation, and increased inflammatory responses, inhibiting neurogenesis. The inhibition of neurogenesis exacerbates neurodegenerative diseases, which in turn suppress neurogenesis, creating a vicious cycle. A comprehensive understanding of the relationships between VPS35, neurogenesis, and neurodegenerative diseases is beneficial for elucidating the pathogenesis of neurodegenerative diseases. Targeting VPS35 in relation to neurogenesis holds promise for alleviating neurodegenerative diseases. Vacuolar protein sorting 35 (VPS35), a critical component of the retromer complex, plays a pivotal role in the pathogenesis of neurodegenerative diseases (NDs). It is involved in protein transmembrane sorting, facilitating the transport from endosomes to the trans‐Golgi network (TGN) and plasma membrane. Recent investigations have compellingly associated mutations in the VPS35 gene with neurodegenerative disorders such as Parkinson's and Alzheimer's disease. These genetic alterations are implicated in protein misfolding, disrupted autophagic processes, mitochondrial dysregulation, and synaptic impairment. Furthermore, VPS35 exerts a notable impact on neurogenesis by influencing neuronal functionality, protein conveyance, and synaptic performance. Dysregulation or mutation of VPS35 may escalate the progression of neurodegenerative conditions, underscoring its pivotal role in safeguarding neuronal integrity. This review comprehensively discusses the role of VPS35 and its functional impairments in NDs. Furthermore, we provide an overview of the impact of VPS35 on neurogenesis and further explore the intricate relationship between neurogenesis and NDs. These research advancements offer novel perspectives and valuable insights for identifying potential therapeutic targets in the treatment of NDs.

Ablation of Vacuole Protein Sorting 18 (vps18) Gene Leads to Neurodegeneration and Impaired Neuronal Migration by Disrupting Multiple Vesicle Transport Pathways to Lysosomes

Disruption of Nectin-Like 1 Cell Adhesion Molecule Leads to Delayed Axonal Myelination in the CNS

Expression of Low Level of VPS35-mCherry Fusion Protein Diminishes Vps35 Depletion Induced Neuron Terminal Differentiation Deficits and Neurodegenerative Pathology, and Prevents Neonatal Death

Vps18 deficiency inhibits dendritogenesis in Purkinje cells by blocking the lysosomal degradation of Lysyl Oxidase.

Deletion of VPS50 protein in mouse brain impairs synaptic function and behavior

Mutant D620N and VPS35 induces motor dysfunction and impairs DAT-mediated dopamine recycling pathway

Mutant VPS35-D620N Induces Motor Dysfunction and Impairs DAT-mediated Dopamine Recycling Pathway.

Microglial VPS35 Deficiency Impairs Aβ Phagocytosis and Aβ-induced Disease-Associated Microglia, and Enhances Aβ Associated Pathology.

RAB18, a protein associated with Warburg Micro syndrome, controls neuronal migration in the developing cerebral cortex

Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP

Vps35 Regulates Developing Mouse Hippocampal Neuronal Morphogenesis by Promoting Retrograde Trafficking of Bace1

VPS35 Haploinsufficiency Increases Alzheimer’s Disease Neuropathology

MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development

VPS4B deficiency causes early embryonic lethality and induces signal transduction disorders of cell endocytosis

VPS35-deficiency Results in an Impaired AMPA Receptor Trafficking and Decreased Dendritic Spine Maturation

Exploring the triad: VPS35, neurogenesis, and neurodegenerative diseases

Loss of SPNS1, a lysosomal transporter, in the nervous system causes dysmyelination and white matter dysplasia

The yeast dynamin-like protein Vps1:vps1 mutations perturb the internalization and the motility of endocytic vesicles and endosomes via disorganization of the actin cytoskeleton

The Rare Mutation in the Endosome-Associated Recycling Protein Gene VPS50 is Associated with Human Neural Tube Defects.

The double deficiency of the SNARE proteins vti1a and vti1b affects neurite outgrowth and signaling in N1E-115 neuroblastoma cells

Vmp1, Vps13D, and Marf/Mfn2 function in a conserved pathway to regulate mitochondria and ER contact in development and disease